☰

Erik Suuronen - Publications

Affiliations: 
Cellular and Molecular Medicine University of Ottawa, Ottawa, ON, Canada 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jacques E, Hosoyama K, Biniam B, Eren Cimenci C, Sedlakova V, Steeves AJ, Variola F, Davis DR, Stewart DJ, Suuronen EJ, Alarcon EI. Collagen-Based Microcapsules As Therapeutic Materials for Stem Cell Therapies in Infarcted Myocardium. Acs Biomaterials Science & Engineering. 6: 4614-4622. PMID 33455166 DOI: 10.1021/acsbiomaterials.0c00245  0.356
2020 Rafatian G, Kamkar M, Parent S, Michie C, Risha Y, Molgat ASD, Seymour R, Suuronen EJ, Davis DR. Mybl2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction. Aging Cell. PMID 32558221 DOI: 10.1111/acel.13174  0.35
2019 McLaughlin S, McNeill B, Podrebarac J, Hosoyama K, Sedlakova V, Cron G, Smyth D, Seymour R, Goel K, Liang W, Rayner KJ, Ruel M, Suuronen EJ, Alarcon EI. Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction. Nature Communications. 10: 4866. PMID 31653830 DOI: 10.1038/S41467-019-12748-8  0.336
2018 McLaughlin S, McNeill B, Podrebarac J, Hosoyama K, Seymour R, Liang W, Ruel M, Suuronen E, Alarcon E. Injection of a recombinant human collagen hydrogel improves cardiac function and reduces pathological remodeling post myocardial infarction Journal of Molecular and Cellular Cardiology. 124: 104. DOI: 10.1016/J.Yjmcc.2018.07.067  0.387
2018 Pupkaite J, Griffith M, Hilborn J, Suuronen E, Samanta A. Non-toxic chemically crosslinked collagen hydrogels for cell delivery Journal of Molecular and Cellular Cardiology. 124: 104. DOI: 10.1016/J.Yjmcc.2018.07.066  0.319
2018 McNeill B, Vulesevic B, Blackburn N, Ruel M, Suuronen E. An injectable CCN1-collagen matrix for cardiac cell support and treatment of myocardial infarction Journal of Molecular and Cellular Cardiology. 124: 84-85. DOI: 10.1016/J.Yjmcc.2018.07.013  0.414
2017 Rafatian G, Suuronen E, Davis D. Over-Expression Of Mybl2 Rejuvenates Explant Derived Cardiac Stem Cells From Aged Donors With Ischemic Cardiomyopathy Canadian Journal of Cardiology. 33. DOI: 10.1016/J.Cjca.2017.07.057  0.378
2016 Lister Z, Rayner KJ, Suuronen EJ. How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction. Frontiers in Bioengineering and Biotechnology. 4: 62. PMID 27486578 DOI: 10.3389/fbioe.2016.00062  0.359
2016 Tilokee EL, Latham N, Jackson R, Mayfield AE, Ye B, Mount S, Lam BK, Suuronen EJ, Ruel M, Stewart DJ, Davis DR. Paracrine Engineering of Human Explant-Derived Cardiac Stem Cells to Over-Express Stromal-Cell Derived Factor 1α Enhances Myocardial Repair. Stem Cells (Dayton, Ohio). PMID 27059540 DOI: 10.1002/Stem.2373  0.338
2015 Jackson R, Tilokee EL, Latham N, Mount S, Rafatian G, Strydhorst J, Ye B, Boodhwani M, Chan V, Ruel M, Ruddy TD, Suuronen EJ, Stewart DJ, Davis DR. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair. Journal of the American Heart Association. 4: e002104. PMID 26363004 DOI: 10.1161/Jaha.115.002104  0.385
2015 Zhang Y, Kuraitis D, Burgon PG, Crowe S, Vulesevic B, Beanlands RS, deKemp RA, DaSilva JN, Ruel M, Suuronen EJ. Development of reporter gene imaging techniques for long-term assessment of human circulating angiogenic cells. Biomedical Materials (Bristol, England). 10: 034104. PMID 25782444 DOI: 10.1088/1748-6041/10/3/034104  0.304
2015 Blackburn NJ, Sofrenovic T, Kuraitis D, Ahmadi A, McNeill B, Deng C, Rayner KJ, Zhong Z, Ruel M, Suuronen EJ. Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction. Biomaterials. 39: 182-92. PMID 25468370 DOI: 10.1016/J.Biomaterials.2014.11.004  0.331
2015 McNeill B, Vulesevic B, Ostojic A, Ruel M, Suuronen EJ. Collagen matrix-induced expression of integrin αVβ3 in circulating angiogenic cells can be targeted by matricellular protein CCN1 to enhance their function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1198-207. PMID 25466895 DOI: 10.1096/Fj.14-261586  0.301
2015 Rafatian G, Kamkar M, Seymour R, Burgon P, Suuronen E, Davis D. The Molecular Signature Of Cscs Sourced From Aged Donors With Ischemic Cardiomyopathy Impairs Cell Cycle Control And Repair Canadian Journal of Cardiology. 31. DOI: 10.1016/J.Cjca.2015.07.319  0.316
2014 Ahmadi A, McNeill B, Vulesevic B, Kordos M, Mesana L, Thorn S, Renaud JM, Manthorp E, Kuraitis D, Toeg H, Mesana TG, Davis DR, Beanlands RS, DaSilva JN, deKemp RA, ... ... Suuronen EJ, et al. The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. Biomaterials. 35: 4749-58. PMID 24631247 DOI: 10.1016/J.Biomaterials.2014.02.028  0.318
2014 Mayfield AE, Tilokee EL, Latham N, McNeill B, Lam BK, Ruel M, Suuronen EJ, Courtman DW, Stewart DJ, Davis DR. The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials. 35: 133-42. PMID 24099706 DOI: 10.1016/J.Biomaterials.2013.09.085  0.386
2013 Ellis CE, Vulesevic B, Suuronen E, Yeung T, Seeberger K, Korbutt GS. Bioengineering a highly vascularized matrix for the ectopic transplantation of islets Islets. 5: 216-225. PMID 24262950 DOI: 10.4161/Isl.27175  0.354
2013 Toeg HD, Tiwari-Pandey R, Seymour R, Ahmadi A, Crowe S, Vulesevic B, Suuronen EJ, Ruel M. Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. The Annals of Thoracic Surgery. 96: 1686-94; discussion . PMID 24083799 DOI: 10.1016/J.Athoracsur.2013.06.063  0.307
2013 Latham N, Ye B, Jackson R, Lam BK, Kuraitis D, Ruel M, Suuronen EJ, Stewart DJ, Davis DR. Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium. Circulation. 128: S105-12. PMID 24030393 DOI: 10.1161/Circulationaha.112.000374  0.343
2013 Tiwari-Pandey R, Toeg H, Seymour R, Ahmadi A, Crowe S, Vulesevic B, Suuronen E, Ruel M. Effects and Mechanistic Correlates of Using a Liquefied, Injectable Porcine Submucosa Extracellular Matrix, With Or Without Angiogenic Cells, in a Myocardial Scar Model Canadian Journal of Cardiology. 29. DOI: 10.1016/J.Cjca.2013.07.635  0.384
2013 Jackson R, Tilokee EL, Latham N, Ye B, Lam B, Ruel M, Boodhwani M, Rubens FD, Chan V, Mesana TG, Suuronen E, Stewart DJ, Davis DR. Paracrine Engineering of Human Cardiac Stem Cells to Over-Express Insulin-Like Growth Factor-1 Prevents Cell Death and Enhances Ischemic Myocardial Repair Canadian Journal of Cardiology. 29. DOI: 10.1016/J.Cjca.2013.07.382  0.385
2013 Molgat A, Latham N, Tilokee E, Fitzpatrick M, Hay G, Seymour R, Vulesevic B, Lam K, Ruel M, Milne R, Suuronen E, Davis D. Diabetes Inhibits Cardiac Stem Cell Function and Cell-Mediated Cardiac Repair Through High Glucose-Associated Effects on Pro-Angiogenic Capacity Canadian Journal of Cardiology. 29: S117. DOI: 10.1016/J.Cjca.2013.07.158  0.378
2011 McDonald SM, Matheson LA, McBane JE, Kuraitis D, Suuronen E, Santerre JP, Labow RS. Use of monocyte/endothelial cell co-cultures (in vitro) and a subcutaneous implant mouse model (in vivo) to evaluate a degradable polar hydrophobic ionic polyurethane. Journal of Cellular Biochemistry. 112: 3762-72. PMID 21826703 DOI: 10.1002/Jcb.23307  0.325
2010 Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, Yang AF, Griffith M, Ruel M, Suuronen EJ. A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Engineering. Part A. 16: 3099-109. PMID 20586613 DOI: 10.1089/Ten.Tea.2009.0504  0.313
2010 Schussler O, Chachques JC, Mesana TG, Suuronen EJ, Lecarpentier Y, Ruel M. 3-dimensional structures to enhance cell therapy and engineer contractile tissue. Asian Cardiovascular & Thoracic Annals. 18: 188-98. PMID 20304859 DOI: 10.1177/0218492310361531  0.33
2008 Ruel M, Stewart AF, Suuronen EJ. From genes to regenerative medicine: approaches in development. Circulation Research. 103: 1050-2. PMID 18988900 DOI: 10.1161/Circresaha.108.187971  0.31
2008 Suuronen EJ, Kuraitis D, Ruel M. Improving cell engraftment with tissue engineering. Seminars in Thoracic and Cardiovascular Surgery. 20: 110-4. PMID 18707642 DOI: 10.1053/J.Semtcvs.2008.03.005  0.368
2007 Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, Wong S, Mesana TG, Ruel M. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. The Journal of Thoracic and Cardiovascular Surgery. 134: 1249-58. PMID 17976457 DOI: 10.1016/J.Jtcvs.2007.07.028  0.334
2003 Li F, Carlsson D, Lohmann C, Suuronen E, Vascotto S, Kobuch K, Sheardown H, Munger R, Nakamura M, Griffith M. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proceedings of the National Academy of Sciences of the United States of America. 100: 15346-51. PMID 14660789 DOI: 10.1073/Pnas.2536767100  0.333
2002 Griffith M, Hakim M, Shimmura S, Watsky MA, Li F, Carlsson D, Doillon CJ, Nakamura M, Suuronen E, Shinozaki N, Nakata K, Sheardown H. Artificial human corneas: scaffolds for transplantation and host regeneration. Cornea. 21: S54-61. PMID 12484700 DOI: 10.1097/01.Ico.0000263120.68768.F8  0.304
Show low-probability matches.